Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


The Angels Initiative

Stroke prevention


  Neurosurgery

  Free Subscription


Articles published in Int J Radiat Oncol Biol Phys

Retrieve available abstracts of 219 articles:
HTML format



Single Articles


    June 2022
  1. VICENTE EM, Modiri A, Kipritidis J, Yu KC, et al
    Combining Serial and Parallel Functionality in Functional Lung Avoidance Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;113:456-468.
    PubMed     Abstract available


    May 2022
  2. MOUSTAKIS C, Blanck O, Chan MKH, Boda-Heggemann J, et al
    Planning Benchmark Study for Stereotactic Body Radiation Therapy of Liver Metastases: Results of the DEGRO/DGMP Working Group on Stereotactic Radiation Therapy and Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2022;113:214-227.
    PubMed     Abstract available


    April 2022
  3. PIELKENROOD BJ, Gal R, Kasperts N, Verhoeff JJC, et al
    Quality of Life After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2022;112:1203-1215.
    PubMed     Abstract available


  4. SODJI QH, Ko R, von Eyben R, Owen SG, et al
    Acute and Late Esophageal Toxicity After SABR to Thoracic Tumors Near or Abutting the Esophagus.
    Int J Radiat Oncol Biol Phys. 2022;112:1144-1153.
    PubMed     Abstract available


    March 2022
  5. JIAO Z, Li H, Xiao Y, Dorsey J, et al
    Integration of Deep Learning Radiomics and Counts of Circulating Tumor Cells Improves Prediction of Outcomes of Early Stage NSCLC Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2022;112:1045-1054.
    PubMed     Abstract available


  6. SWAMINATH A, Ritter T, Louie AV, Palma DA, et al
    Performing SBRT in the Fly-With-Caution Zone: Are We Heeding the Advice of Daedalus?
    Int J Radiat Oncol Biol Phys. 2022;112:586-589.
    PubMed    


  7. MENDIRATTA-LALA M, Aslam A, Maturen KE, Westerhoff M, et al
    LI-RADS Treatment Response Algorithm: Performance and Diagnostic Accuracy With Radiologic-Pathologic Explant Correlation in Patients With SBRT-Treated Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2022;112:704-714.
    PubMed     Abstract available


    February 2022
  8. HRYCUSHKO B, van der Kogel AJ, Phillips L, Chhabra A, et al
    Brachial Plexus Tolerance to Single-Session SABR in a Pig Model.
    Int J Radiat Oncol Biol Phys. 2022;112:565-571.
    PubMed     Abstract available


  9. NGUYEN TK, Chin L, Sahgal A, Dagan R, et al
    International Multi-institutional Patterns of Contouring Practice and Clinical Target Volume Recommendations for Stereotactic Body Radiation Therapy for Non-Spine Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2022;112:351-360.
    PubMed     Abstract available


    January 2022
  10. MATHIS NJ, Doyle CJ, Rosen DB, Wijetunga NA, et al
    Personalized Treatment Selection Leads to Low Rates of Local Salvage Therapy for Bone Metastases.
    Int J Radiat Oncol Biol Phys. 2022;112:99-105.
    PubMed     Abstract available


  11. LEEMAN JE, Chen YH, Catalano P, Bredfeldt J, et al
    Radiation Dose to the Intraprostatic Urethra Correlates Strongly With Urinary Toxicity After Prostate Stereotactic Body Radiation Therapy: A Combined Analysis of 23 Prospective Clinical Trials.
    Int J Radiat Oncol Biol Phys. 2022;112:75-82.
    PubMed     Abstract available


  12. KHATTAB MH, Cmelak AJ, Sherry AD, Luo G, et al
    Noninvasive Thalamotomy for Refractory Tremor by Frameless Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2022;112:121-130.
    PubMed     Abstract available


  13. DUNNE EM, Lo SS, Liu MC, Bergman A, et al
    Thecal Sac Contouring as a Surrogate for the Cauda Equina and Intracanal Spinal Nerve Roots for Spine Stereotactic Body Radiation Therapy (SBRT): Contour Variability and Recommendations for Safe Practice.
    Int J Radiat Oncol Biol Phys. 2022;112:114-120.
    PubMed     Abstract available


  14. MILLER JA, Toesca DAS, Baclay JRM, Vitzthum LK, et al
    Pancreatic Stereotactic Body Radiation Therapy With or Without Hypofractionated Elective Nodal Irradiation.
    Int J Radiat Oncol Biol Phys. 2022;112:131-142.
    PubMed     Abstract available


    December 2021
  15. LEE K, Le T, Hau E, Hanna GG, et al
    A systematic review into the radiological features predicting local recurrence after stereotactic ablative body radiotherapy (SABR) in patients with non-small cell lung cancer (NSCLC): Local recurrence features of NSCLC post-SABR.
    Int J Radiat Oncol Biol Phys. 2021 Dec 5. pii: S0360-3016(21)03235.
    PubMed     Abstract available


  16. NIEDZIELSKI JS, Liu Y, Ng SSW, Martin RM, et al
    Dosimetric Uncertainties Resulting From Interfractional Anatomic Variations for Patients Receiving Pancreas Stereotactic Body Radiation Therapy and Cone Beam Computed Tomography Image Guidance.
    Int J Radiat Oncol Biol Phys. 2021;111:1298-1309.
    PubMed     Abstract available


    November 2021
  17. UEKI K, Matsuo Y, Takeda A, Morita S, et al
    Impact of local recurrence on cause-specific death after stereotactic body radiotherapy for early-stage non-small cell lung cancer: dynamic prediction using landmark model.
    Int J Radiat Oncol Biol Phys. 2021 Nov 25. pii: S0360-3016(21)03223.
    PubMed     Abstract available


  18. CHEN X, Redmond KJ
    There Will Be Blood: Not All AVM Complications Are Due to Radiation.
    Int J Radiat Oncol Biol Phys. 2021;111:855.
    PubMed    


  19. ITO K, Sugita S, Nakajima Y, Furuya T, et al
    Phase II Clinical Trial of Separation Surgery Followed by Stereotactic Body Radiotherapy for Metastatic Epidural Spinal Cord Compression.
    Int J Radiat Oncol Biol Phys. 2021;111.
    PubMed     Abstract available


  20. YANG HC, Wu HM, Peng SJ, Lee CC, et al
    The Irradiated Brain Volume Within 12 Gy Is a Predictor for Radiation-Induced Changes After Stereotactic Radiosurgery in Patients With Unruptured Cerebral Arteriovenous Malformations.
    Int J Radiat Oncol Biol Phys. 2021;111:785-793.
    PubMed     Abstract available


    October 2021
  21. KOWALCHUK RO, Niranjan A, Lee CC, Yang HC, et al
    yReirradiation with stereotactic radiosurgery after local or marginal recurrence of brain metastases from previous radiosurgery.
    Int J Radiat Oncol Biol Phys. 2021 Oct 10. pii: S0360-3016(21)02904.
    PubMed     Abstract available


  22. RABEN D, Raben A
    A Two-Headed Heated Debate.
    Int J Radiat Oncol Biol Phys. 2021;111:310.
    PubMed    


  23. PERDOMO-PANTOJA A, Holmes C, Lina IA, Liauw JA, et al
    Effects of Single-Dose Versus Hypofractionated Focused Radiation on Vertebral Body Structure and Biomechanical Integrity: Development of a Rabbit Radiation-Induced Vertebral Compression Fracture Model.
    Int J Radiat Oncol Biol Phys. 2021;111:528-538.
    PubMed     Abstract available


    September 2021
  24. AMINI A, Verma V, Simone CB 2nd, Chetty IJ, et al
    American Radium Society Appropriate Use Criteria on Radiation Therapy in Oligometastatic or Oligoprogressive Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Sep 24. pii: S0360-3016(21)02823.
    PubMed     Abstract available


  25. MYREHAUG S, Hudson J, Soliman H, Ruschin M, et al
    Hypofractionated Stereotactic Radiotherapy for Intact Brain Metastases in 5 Daily Fractions: Impact of Dose on Treatment Response.
    Int J Radiat Oncol Biol Phys. 2021 Sep 16. pii: S0360-3016(21)02784.
    PubMed     Abstract available


  26. NAGAR H, Spratt DE
    Prostate SBRT Dose Escalation (9 Gyx5, 13.3 Gyx3, 24 Gyx1): Are We Making Progress?
    Int J Radiat Oncol Biol Phys. 2021;111:110-112.
    PubMed    


  27. REDMOND KJ, De Salles AAF, Fariselli L, Levivier M, et al
    Stereotactic Radiosurgery for Postoperative Metastatic Surgical Cavities: A Critical Review and International Stereotactic Radiosurgery Society (ISRS) Practice Guidelines.
    Int J Radiat Oncol Biol Phys. 2021;111:68-80.
    PubMed     Abstract available


  28. JACKSON WC, Hartman HE, Gharzai LA, Maurino C, et al
    The Potential for Midtreatment Albumin-Bilirubin (ALBI) Score to Individualize Liver Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;111:127-134.
    PubMed     Abstract available


  29. BROWNSTEIN J, Afzal M, Okabe T, Harfi TT, et al
    Method and Atlas to Enable Targeting for Cardiac Radioablation Employing the American Heart Association Segmented Model.
    Int J Radiat Oncol Biol Phys. 2021;111:178-185.
    PubMed     Abstract available


  30. MAGALLON-BARO A, Milder MTW, Granton PV, Nuyttens JJ, et al
    Comparison of Daily Online Plan Adaptation Strategies for a Cohort of Pancreatic Cancer Patients Treated with SBRT.
    Int J Radiat Oncol Biol Phys. 2021;111:208-219.
    PubMed     Abstract available


    August 2021
  31. HENKE LE, Stanley JA, Robinson C, Srivastava A, et al
    Phase I Trial of Stereotactic MRI-guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Aug 30. pii: S0360-3016(21)02726.
    PubMed     Abstract available


  32. ITO K, Ogawa H
    Stereotactic Body Radiation Therapy for Patients With Sacral Chordoma Who Previously Received Carbon Ion Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:1263-1264.
    PubMed    


  33. MOORE C, Hsu CC, Chen WM, Chen BPC, et al
    Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade.
    Int J Radiat Oncol Biol Phys. 2021;110:1306-1316.
    PubMed     Abstract available


  34. PRASANNA PG, Rawojc K, Guha C, Buchsbaum JC, et al
    Normal Tissue Injury Induced by Photon and Proton Therapies: Gaps and Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:1325-1340.
    PubMed     Abstract available


    July 2021
  35. ITO K, Sugita S, Nakajima Y, Furuya T, et al
    Phase II clinical trial of separation surgery followed by stereotactic body radiotherapy for metastatic epidural spinal cord compression.
    Int J Radiat Oncol Biol Phys. 2021 Jul 23. pii: S0360-3016(21)02560.
    PubMed     Abstract available


  36. SOYFER V, Gutfeld O, Shamai S, Schlocker A, et al
    COVID-19 Vaccine-Induced Radiation Recall Phenomenon.
    Int J Radiat Oncol Biol Phys. 2021;110:957-961.
    PubMed     Abstract available


  37. CHOUDHURY A, Henry Md Frcr A, Mitin Md PhD T, Chen Md Mph R, et al
    Photons, Protons, SBRT, Brachytherapy-What Is Leading the Charge for the Management of Prostate Cancer? A Perspective From the GU Editorial Team.
    Int J Radiat Oncol Biol Phys. 2021;110:1114-1121.
    PubMed    


  38. COURTNEY PT, Paravati AJ, Atwood TF, Raja N, et al
    Phase I Trial of Stereotactic Body Radiation Therapy Dose Escalation in Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:1003-1012.
    PubMed     Abstract available


  39. MARGULIS V, Freifeld Y, Pop LM, Manna S, et al
    Neoadjuvant SABR for Renal Cell Carcinoma Inferior Vena Cava Tumor Thrombus-Safety Lead-in Results of a Phase 2 Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:1135-1142.
    PubMed     Abstract available


  40. BISWAS T, Spratt DE
    Dose Escalation for Oligometastatic Disease: Is More Better?
    Int J Radiat Oncol Biol Phys. 2021;110:680-681.
    PubMed    


  41. BODA-HEGGEMANN J, Blanck O, Mehrhof F, Ernst F, et al
    Interdisciplinary Clinical Target Volume Generation for Cardiac Radioablation: Multicenter Benchmarking for the RAdiosurgery for VENtricular TAchycardia (RAVENTA) Trial.
    Int J Radiat Oncol Biol Phys. 2021;110:745-756.
    PubMed     Abstract available


  42. VAN DAMS R, Jiang NY, Fuller DB, Loblaw A, et al
    Stereotactic Body Radiotherapy for High-Risk Localized Carcinoma of the Prostate (SHARP) Consortium: Analysis of 344 Prospectively Treated Patients.
    Int J Radiat Oncol Biol Phys. 2021;110:731-737.
    PubMed     Abstract available


  43. ZELEFSKY MJ, Yamada Y, Greco C, Lis E, et al
    Phase 3 Multi-Center, Prospective, Randomized Trial Comparing Single-Dose 24 Gy Radiation Therapy to a 3-Fraction SBRT Regimen in the Treatment of Oligometastatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:672-679.
    PubMed     Abstract available


    June 2021
  44. HOSKIN MD FRCR P
    Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2, Randomized Controlled Trial Within a Prospective Cohort.
    Int J Radiat Oncol Biol Phys. 2021;110:368-370.
    PubMed    


  45. GUCKENBERGER M, Mantel F, Sweeney RA, Hawkins M, et al
    Long-Term Results of Dose-Intensified Fractionated Stereotactic Body Radiation Therapy (SBRT) for Painful Spinal Metastases.
    Int J Radiat Oncol Biol Phys. 2021;110:348-357.
    PubMed     Abstract available


  46. PARK JH, Kim HY, Lee A, Seo YK, et al
    Enlightening the Immune Mechanism of the Abscopal Effect in a Murine HCC Model and Overcoming the Late Resistance With Anti-PD-L1.
    Int J Radiat Oncol Biol Phys. 2021;110:510-520.
    PubMed     Abstract available


  47. PIELKENROOD BJ, van der Velden JM, van der Linden YM, Bartels MMT, et al
    Pain Response After Stereotactic Body Radiation Therapy Versus Conventional Radiation Therapy in Patients With Bone Metastases-A Phase 2 Randomized Controlled Trial Within a Prospective Cohort.
    Int J Radiat Oncol Biol Phys. 2021;110:358-367.
    PubMed     Abstract available


    May 2021
  48. PRABHU RS, Dhakal R, Vaslow ZK, Dan T, et al
    Preoperative radiosurgery for resected brain metastases: the PROPS-BM multicenter cohort study.
    Int J Radiat Oncol Biol Phys. 2021 May 28. pii: S0360-3016(21)00666.
    PubMed     Abstract available


  49. VIDETIC GMM, Reddy CA, Woody NM, Stephans KL, et al
    Ten-Year Experience in Implementing Single-Fraction Lung SBRT for Medically Inoperable Early Stage Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021 May 25. pii: S0360-3016(21)00658.
    PubMed     Abstract available


  50. STUMPF PK, Yorke ED, El Naqa I, Cuneo KC, et al
    Modeling of Tumor Control Probability in Stereotactic Body Radiation Therapy for Adrenal Tumors.
    Int J Radiat Oncol Biol Phys. 2021;110:217-226.
    PubMed     Abstract available


  51. GRIMM J, Marks LB, Jackson A, Kavanagh BD, et al
    High Dose per Fraction, Hypofractionated Treatment Effects in the Clinic (HyTEC): An Overview.
    Int J Radiat Oncol Biol Phys. 2021;110:1-10.
    PubMed    


  52. GRIMM J, Vargo JA, Mavroidis P, Moiseenko V, et al
    Initial Data Pooling for Radiation Dose-Volume Tolerance for Carotid Artery Blowout and Other Bleeding Events in Hypofractionated Head and Neck Retreatments.
    Int J Radiat Oncol Biol Phys. 2021;110:147-159.
    PubMed     Abstract available


  53. SOLTYS SG, Grimm J, Milano MT, Xue J, et al
    Stereotactic Body Radiation Therapy for Spinal Metastases: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Int J Radiat Oncol Biol Phys. 2021;110:112-123.
    PubMed     Abstract available


  54. MAHADEVAN A, Moningi S, Grimm J, Li XA, et al
    Maximizing Tumor Control and Limiting Complications With Stereotactic Body Radiation Therapy for Pancreatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:206-216.
    PubMed     Abstract available


  55. WANG K, Mavroidis P, Royce TJ, Falchook AD, et al
    Prostate Stereotactic Body Radiation Therapy: An Overview of Toxicity and Dose Response.
    Int J Radiat Oncol Biol Phys. 2021;110:237-248.
    PubMed     Abstract available


  56. MILANO MT, Grimm J, Niemierko A, Soltys SG, et al
    Single- and Multifraction Stereotactic Radiosurgery Dose/Volume Tolerances of the Brain.
    Int J Radiat Oncol Biol Phys. 2021;110:68-86.
    PubMed     Abstract available


  57. SAHGAL A, Chang JH, Ma L, Marks LB, et al
    Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;110:124-136.
    PubMed     Abstract available


  58. LEE P, Loo BW Jr, Biswas T, Ding GX, et al
    Local Control After Stereotactic Body Radiation Therapy for Stage I Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2021;110:160-171.
    PubMed     Abstract available


  59. MARCISCANO AE, Haimovitz-Friedman A, Lee P, Tran PT, et al
    Immunomodulatory Effects of Stereotactic Body Radiation Therapy: Preclinical Insights and Clinical Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;110:35-52.
    PubMed    


  60. SONG CW, Glatstein E, Marks LB, Emami B, et al
    Biological Principles of Stereotactic Body Radiation Therapy (SBRT) and Stereotactic Radiation Surgery (SRS): Indirect Cell Death.
    Int J Radiat Oncol Biol Phys. 2021;110:21-34.
    PubMed     Abstract available


  61. KONG FS, Moiseenko V, Zhao J, Milano MT, et al
    Organs at Risk Considerations for Thoracic Stereotactic Body Radiation Therapy: What Is Safe for Lung Parenchyma?
    Int J Radiat Oncol Biol Phys. 2021;110:172-187.
    PubMed     Abstract available


  62. MILANO MT, Grimm J, Soltys SG, Yorke E, et al
    Single- and Multi-Fraction Stereotactic Radiosurgery Dose Tolerances of the Optic Pathways.
    Int J Radiat Oncol Biol Phys. 2021;110:87-99.
    PubMed     Abstract available


  63. MIFTEN M, Vinogradskiy Y, Moiseenko V, Grimm J, et al
    Radiation Dose-Volume Effects for Liver SBRT.
    Int J Radiat Oncol Biol Phys. 2021;110:196-205.
    PubMed     Abstract available


  64. OHRI N, Tome WA, Mendez Romero A, Miften M, et al
    Local Control After Stereotactic Body Radiation Therapy for Liver Tumors.
    Int J Radiat Oncol Biol Phys. 2021;110:188-195.
    PubMed     Abstract available


    April 2021
  65. TATEISHI Y, Takeda A, Horita N, Tsurugai Y, et al
    Stereotactic body radiotherapy with a high maximum dose improves local control, cancer-specific death and overall survival in peripheral early-stage non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2021 Apr 20. pii: S0360-3016(21)00375.
    PubMed     Abstract available


  66. MENDEZ ROMERO A, Schillemans W, van Os R, Koppe F, et al
    The Dutch-Belgian Registry of Stereotactic Body Radiation Therapy for Liver Metastases: Clinical Outcomes of 515 Patients and 668 Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1377-1386.
    PubMed     Abstract available


  67. FOLKERT MR, Meyer JJ, Aguilera TA, Yokoo T, et al
    Long-Term Results of a Phase 1 Dose-Escalation Trial and Subsequent Institutional Experience of Single-Fraction Stereotactic Ablative Radiation Therapy for Liver Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:1387-1395.
    PubMed     Abstract available


  68. QU XM, Chen Y, Zaric GS, Senan S, et al
    Is SABR Cost-Effective in Oligometastatic Cancer? An Economic Analysis of the SABR-COMET Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1176-1184.
    PubMed     Abstract available


  69. MERCIER C, Claessens M, Buys MSc A, Gryshkevych S, et al
    Stereotactic Ablative Radiation Therapy to All Lesions in Patients With Oligometastatic Cancers: A Phase 1 Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2021;109:1195-1205.
    PubMed     Abstract available


  70. VAN LIMBERGEN EJ, Hoeben A, Lieverse RIY, Houben R, et al
    Toxicity of L19-Interleukin 2 Combined with Stereotactic Body Radiation Therapy: A Phase 1 Study.
    Int J Radiat Oncol Biol Phys. 2021;109:1421-1430.
    PubMed     Abstract available


  71. TINKLE CL, Singh C, Lloyd S, Guo Y, et al
    Stereotactic Body Radiation Therapy for Metastatic and Recurrent Solid Tumors in Children and Young Adults.
    Int J Radiat Oncol Biol Phys. 2021;109:1396-1405.
    PubMed     Abstract available


  72. ZHANG J, Wang L, Li X, Huang M, et al
    Quantification of Intrafraction and Interfraction Tumor Motion Amplitude and Prediction Error for Different Liver Tumor Trajectories in Cyberknife Synchrony Tracking.
    Int J Radiat Oncol Biol Phys. 2021;109:1588-1605.
    PubMed     Abstract available


  73. KUMAR A, Straka C, Courtney PT, Vitzthum L, et al
    Cost-Effectiveness Analysis of Stereotactic Ablative Radiation Therapy in Patients With Oligometastatic Cancer.
    Int J Radiat Oncol Biol Phys. 2021;109:1185-1194.
    PubMed     Abstract available


    March 2021
  74. MAGLI A, Farneti A, Faiella A, Ferriero M, et al
    Toxicity at 1 year after Stereotactic Body Radiotherapy in 3 Fractions for Localized Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2021 Mar 18. pii: S0360-3016(21)00287.
    PubMed     Abstract available


  75. SANTOS PMG, Lapen K, Zhang Z, Lobaugh S, et al
    Trends in Radiation Therapy for Bone Metastases, 2015 to 2017: Choosing Wisely in the Era of Complex Radiation.
    Int J Radiat Oncol Biol Phys. 2021;109:923-931.
    PubMed     Abstract available


  76. ZHANG J, Wang C, Sheng Y, Palta M, et al
    An Interpretable Planning Bot for Pancreas Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:1076-1085.
    PubMed     Abstract available


  77. LYDIARD PGDIP S, Blanck O, Hugo G, O'Brien R, et al
    A Review of Cardiac Radioablation (CR) for Arrhythmias: Procedures, Technology, and Future Opportunities.
    Int J Radiat Oncol Biol Phys. 2021;109:783-800.
    PubMed     Abstract available


  78. SHAHI J, Poon I, Ung YC, Tsao M, et al
    Stereotactic Body Radiation Therapy for Mediastinal and Hilar Lymph Node Metastases.
    Int J Radiat Oncol Biol Phys. 2021;109:764-774.
    PubMed     Abstract available


  79. SOGONO P, Bressel M, David S, Shaw M, et al
    Safety, Efficacy, and Patterns of Failure After Single-Fraction Stereotactic Body Radiation Therapy (SBRT) for Oligometastases.
    Int J Radiat Oncol Biol Phys. 2021;109:756-763.
    PubMed     Abstract available


    February 2021
  80. KOWALCHUK RO, Shepard MJ, Sheehan K, Sheehan D, et al
    Treatment of WHO grade II meningiomas with stereotactic radiosurgery: identification of an optimal group for SRS using RPA.
    Int J Radiat Oncol Biol Phys. 2021 Feb 3. pii: S0360-3016(21)00122.
    PubMed     Abstract available


  81. DUNNE EM, Liu M
    Postoperative Stereotactic Body Radiation Therapy, Then Observe.
    Int J Radiat Oncol Biol Phys. 2021;109:316.
    PubMed    


  82. DE BARI B
    Cautious SBRT.
    Int J Radiat Oncol Biol Phys. 2021;109:315.
    PubMed    


  83. KIM N, Cheng J, Huang WY, Kimura T, et al
    Dose-Response Relationship in Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma: A Pooled Analysis of an Asian Liver Radiation Therapy Group Study.
    Int J Radiat Oncol Biol Phys. 2021;109:464-473.
    PubMed     Abstract available


  84. LO CH, Lee HL, Hsiang CW, Chiou JF, et al
    Pretreatment Neutrophil-to-Lymphocyte Ratio Predicts Survival and Liver Toxicity in Patients With Hepatocellular Carcinoma Treated With Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2021;109:474-484.
    PubMed     Abstract available


    January 2021
  85. SALAMA JK, Giuliani ME, Robinson CG, Daly ME, et al
    Single-fraction SBRT for Early Stage NSCLC-A Viable Option in "These Uncertain Times"?
    Int J Radiat Oncol Biol Phys. 2021;109:1-4.
    PubMed    


  86. JACKSON WC, Tang M, Maurino C, Mendiratta-Lala M, et al
    Individualized Adaptive Radiation Therapy Allows for Safe Treatment of Hepatocellular Carcinoma in Patients With Child-Turcotte-Pugh B Liver Disease.
    Int J Radiat Oncol Biol Phys. 2021;109:212-219.
    PubMed     Abstract available


    December 2020
  87. REDMOND KJ, Gui C, Benedict S, Milano MT, et al
    Tumor Control Probability of Radiosurgery and Fractionated Stereotactic Radiosurgery for Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2020 Dec 31. pii: S0360-3016(20)34451.
    PubMed     Abstract available


  88. CHEN WC, Li Y, Lazar A, Altan A, et al
    Stereotactic body radiotherapy and high-dose rate brachytherapy boost in combination with intensity modulated radiotherapy for localized prostate cancer: a single-institution propensity score matched analysis.
    Int J Radiat Oncol Biol Phys. 2020 Dec 29. pii: S0360-3016(20)34730.
    PubMed     Abstract available


  89. SOLTYS SG, Milano MT, Xue J, Tome WA, et al
    Stereotactic Radiosurgery for Vestibular Schwannomas: Tumor Control Probability Analyses and Recommended Reporting Standards.
    Int J Radiat Oncol Biol Phys. 2020 Dec 26. pii: S0360-3016(20)34541.
    PubMed     Abstract available


  90. MCDONALD BA, Vedam S, Yang J, Wang J, et al
    Initial Feasibility and Clinical Implementation of Daily MR-guided Adaptive Head and Neck Cancer Radiotherapy on a 1.5T MR-Linac System: Prospective R-IDEAL 2a/2b Systematic Clinical Evaluation of Technical Innovation.
    Int J Radiat Oncol Biol Phys. 2020 Dec 16. pii: S0360-3016(20)34661.
    PubMed     Abstract available


  91. JIAO Z, Li H, Xiao Y, Aggarwal C, et al
    Integration of risk survival measures estimated from pre- and post-treatment CT scans improves stratification of early stage non-small cell lung cancer patients treated with stereotactic body radiation therapy.
    Int J Radiat Oncol Biol Phys. 2020 Dec 14. pii: S0360-3016(20)34660.
    PubMed     Abstract available


  92. TANG C, Lei X, Smith GL, Pan HY, et al
    Influence of Geography on Prostate Cancer Treatment.
    Int J Radiat Oncol Biol Phys. 2020 Dec 11. pii: S0360-3016(20)34595.
    PubMed     Abstract available


  93. KIMURA T, Takeda A, Tsurugai Y, Kawano R, et al
    A Multi-Institutional Retrospective Study of Repeated Stereotactic Body Radiation Therapy for Intrahepatic Recurrent Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020;108:1265-1275.
    PubMed     Abstract available


  94. SEBASTIAN NT, Miller ED, Yang X, Diaz DA, et al
    A Pilot Trial Evaluating Stereotactic Body Radiation Therapy to Induce Hyperemia in Combination With Transarterial Chemoembolization for Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020;108:1276-1283.
    PubMed     Abstract available


  95. DEE EC, Muralidhar V, Arega MA, Kishan AU, et al
    Factors influencing non-completion of radiotherapy among men with localized prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Dec 1. pii: S0360-3016(20)34604.
    PubMed     Abstract available


    November 2020
  96. SPENCER KL, Tree AC
    Commentary on Cost-Effectiveness of Metastasis-Directed Therapy in Oligorecurrent Hormone-Sensitive Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020;108:927-929.
    PubMed    


  97. BURRI SH, Ward MC, Prabhu RS
    Hobgoblins, Iron Lungs, and Surgical Perturbation Failure?
    Int J Radiat Oncol Biol Phys. 2020;108:996-998.
    PubMed    


  98. VASQUEZ OSORIO EM, McCallum H, Bedair A, Faivre-Finn C, et al
    Protecting the Heart: A Practical Approach to Account for the Full Extent of Heart Motion in Radiation Therapy Planning.
    Int J Radiat Oncol Biol Phys. 2020;108:1082-1090.
    PubMed     Abstract available


  99. PARIKH NR, Kundu P, Levin-Epstein R, Chang EM, et al
    Time-Driven Activity-Based Costing Comparison of Stereotactic Radiosurgery to Multiple Brain Lesions Using Single-Isocenter Versus Multiple-Isocenter Technique.
    Int J Radiat Oncol Biol Phys. 2020;108:999-1007.
    PubMed     Abstract available


  100. SIVA S, Correa RJM, Warner A, Staehler M, et al
    Stereotactic Ablative Radiotherapy for >/=T1b Primary Renal Cell Carcinoma: A Report From the International Radiosurgery Oncology Consortium for Kidney (IROCK).
    Int J Radiat Oncol Biol Phys. 2020;108:941-949.
    PubMed     Abstract available


  101. GOGINENI E, Rana Z, Soberman D, Sidiqi B, et al
    Biochemical control and toxicity outcomes of SBRT vs LDR brachytherapy in the treatment of low and intermediate risk prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Nov 7. pii: S0360-3016(20)34489.
    PubMed     Abstract available


  102. JOHNSTONE C, Recht A
    It's Time...
    Int J Radiat Oncol Biol Phys. 2020;108:572-574.
    PubMed    


  103. YU JB, Brock KK, Campbell AM, Chen AB, et al
    Proceedings of the ASTRO-RSNA Oligometastatic Disease Research Workshop.
    Int J Radiat Oncol Biol Phys. 2020;108:539-545.
    PubMed     Abstract available


  104. BYUN HK, Yoon HI, Cho J, Shim KW, et al
    Optimization of Intracranial Germinoma Treatment: Radiotherapy Alone with Reduced Volume and Dose.
    Int J Radiat Oncol Biol Phys. 2020;108:657-666.
    PubMed     Abstract available


    October 2020
  105. LING DC, Vargo JA, Beriwal S
    Breast, Prostate, and Rectal Cancer: Should 5-5-5 Be a New Standard of Care?
    Int J Radiat Oncol Biol Phys. 2020;108:390-393.
    PubMed    


    September 2020
  106. SANDERS JW, Venkatesan AM, Levitt CA, Bathala T, et al
    Fully balanced SSFP without an endorectal coil for post-implant QA of MRI-assisted radiosurgery (MARS) of prostate cancer: a prospective study.
    Int J Radiat Oncol Biol Phys. 2020 Sep 24. pii: S0360-3016(20)34342.
    PubMed     Abstract available


  107. ROYCE TJ, Mavroidis P, Wang K, Falchook AD, et al
    Tumor Control Probability Modeling and Systematic Review of the Literature of Stereotactic Body Radiation Therapy for Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Sep 5. pii: S0360-3016(20)34102.
    PubMed     Abstract available


  108. KORPICS MC, Polley MY, Bhave SR, Redler G, et al
    A Validated T Cell Radiomics Score Is Associated With Clinical Outcomes Following Multisite SBRT and Pembrolizumab.
    Int J Radiat Oncol Biol Phys. 2020;108:189-195.
    PubMed     Abstract available


  109. RATNAYAKE G, Reinwald S, Shackleton M, Moore M, et al
    Stereotactic Radiation Therapy Combined With Immunotherapy Against Metastatic Melanoma: Long-Term Results of a Phase 1 Clinical Trial.
    Int J Radiat Oncol Biol Phys. 2020;108:150-156.
    PubMed     Abstract available


  110. TIAN S, Switchenko JM, Buchwald ZS, Patel PR, et al
    Lung Stereotactic Body Radiation Therapy and Concurrent Immunotherapy: A Multicenter Safety and Toxicity Analysis.
    Int J Radiat Oncol Biol Phys. 2020;108:304-313.
    PubMed     Abstract available


    July 2020
  111. BERGAMIN S, Eade T, Kneebone A, Booth J, et al
    Interim results of a prospective PSMA-directed focal stereotactic re-irradiation trial for locally recurrent prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jul 10. pii: S0360-3016(20)31412.
    PubMed     Abstract available


  112. SANDERS JW, Lewis GD, Thames HD, Kudchadker RJ, et al
    Machine segmentation of pelvic anatomy in MRI-assisted radiosurgery (MARS) for prostate cancer brachytherapy.
    Int J Radiat Oncol Biol Phys. 2020 Jul 4. pii: S0360-3016(20)31396.
    PubMed     Abstract available


  113. TSANG RW, Laperriere N
    Whole Brain Radiation Is Still the Standard in the Salvage Situation.
    Int J Radiat Oncol Biol Phys. 2020;107:403.
    PubMed    


  114. BERTHO A, Dos Santos M, Buard V, Paget V, et al
    Preclinical Model of Stereotactic Ablative Lung Irradiation Using Arc Delivery in the Mouse: Effect of Beam Size Changes and Dose Effect at Constant Collimation.
    Int J Radiat Oncol Biol Phys. 2020;107:548-562.
    PubMed     Abstract available


    June 2020
  115. HELIS CA, Hughes RT, Glenn CW, Lanier CM, et al
    Predictors of Adverse Radiation Effect in Brain Metastasis Patients Treated with Stereotactic Radiosurgery and Immune Checkpoint Inhibitor Therapy.
    Int J Radiat Oncol Biol Phys. 2020 Jun 29. pii: S0360-3016(20)31344.
    PubMed     Abstract available


  116. PARIKH NR, Kishan AU, Kane N, Diaz-Perez S, et al
    Phase I Trial of Stereotactic Body Radiotherapy Neoadjuvant to Radical Prostatectomy for Patients with High-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 17. pii: S0360-3016(20)31251.
    PubMed     Abstract available


  117. PARIKH NR, Chang EM, Nickols NG, Rettig MB, et al
    Cost-effectiveness of metastasis-directed therapy in oligorecurrent hormone-sensitive prostate cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jun 13. pii: S0360-3016(20)31250.
    PubMed     Abstract available


  118. JACCARD M, Zilli T, Dubouloz A, Escude L, et al
    Urethra-sparing stereotactic body radiotherapy for prostate cancer: quality assuranceof a randomized phase II trial.
    Int J Radiat Oncol Biol Phys. 2020 Jun 11. pii: S0360-3016(20)31242.
    PubMed     Abstract available


  119. CHANG DT, Pollom EL, Keane FK, Wo JY, et al
    Treating Oligometastatic Disease With SABR: More Than Just a Numbers Game?
    Int J Radiat Oncol Biol Phys. 2020;107:257-260.
    PubMed    


  120. PALMA DA, Bauman GS, Rodrigues GB
    Beyond Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;107:253-256.
    PubMed    


  121. FINAZZI T, Haasbeek CJA, Spoelstra FOB, Palacios MA, et al
    Clinical Outcomes of Stereotactic MR-Guided Adaptive Radiation Therapy for High-Risk Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2020;107:270-278.
    PubMed     Abstract available


  122. AYOUB Z, Ning MS, Brooks ED, Kang J, et al
    Definitive Management of Presumed Synchronous Early Stage Non-Small Cell Lung Cancers: Outcomes and Utility of Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:261-269.
    PubMed     Abstract available


    May 2020
  123. HASEGAWA T, Kato T, Naito T, Tanei T, et al
    Long-term outcomes of sporadic vestibular schwannomas treated with recent stereotactic radiosurgery techniques.
    Int J Radiat Oncol Biol Phys. 2020 May 28. pii: S0360-3016(20)31186.
    PubMed     Abstract available


  124. CHU C, Davis CM, Lan X, Hienz RD, et al
    Neuroinflammation following stereotactic radiosurgery-induced brain tumor disintegration is linked to persistent cognitive decline in a mouse model of metastatic disease.
    Int J Radiat Oncol Biol Phys. 2020 May 26. pii: S0360-3016(20)31151.
    PubMed     Abstract available


  125. RAHIMI A, Zhang Y, Kim DW, Morgan H, et al
    Risk factors for fat necrosis after stereotactic partial breast irradiation (S-PBI) for early stage breast cancer in a phase I clinical trial.
    Int J Radiat Oncol Biol Phys. 2020 May 25. pii: S0360-3016(20)31149.
    PubMed     Abstract available


  126. LIU Q, Zhu Z, Chen Y, Deng J, et al
    Phase II Study of SBRT for Patients With Oligometastatic Esophageal Squamous Cell Carcinoma.
    Int J Radiat Oncol Biol Phys. 2020 May 14. pii: S0360-3016(20)31127.
    PubMed     Abstract available


  127. KASMANN L, Eze C, Manapov F
    Stereotactic Body Radiation Therapy (SBRT) Combined with Immune Check-Point Inhibition (ICI) in Advanced Lung Cancer: Which Metastatic Site Should Be Irradiated to Induce Immunogenic Cell Death?
    Int J Radiat Oncol Biol Phys. 2020 May 12. pii: S0360-3016(20)30987.
    PubMed    


  128. VAN DE VEN S, van den Bongard D, Pielkenrood B, Kasperts N, et al
    Patient-Reported Outcomes of Oligometastatic Patients After Conventional or Stereotactic Radiation Therapy to Bone Metastases: An Analysis of the PRESENT Cohort.
    Int J Radiat Oncol Biol Phys. 2020;107:39-47.
    PubMed     Abstract available


  129. CHEN WC, Baal JD, Baal U, Pai J, et al
    Stereotactic Body Radiation Therapy of Adrenal Metastases: A Pooled Meta-Analysis and Systematic Review of 39 Studies with 1006 Patients.
    Int J Radiat Oncol Biol Phys. 2020;107:48-61.
    PubMed     Abstract available


  130. ALAYED Y, Davidson M, Liu S, Chu W, et al
    Evaluating the Tolerability of a Simultaneous Focal Boost to the Gross Tumor in Prostate SABR: A Toxicity and Quality-of-Life Comparison of Two Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2020;107:136-142.
    PubMed     Abstract available


  131. GUO T, Ni J, Yang X, Li Y, et al
    Pattern of Recurrence Analysis in Metastatic EGFR-Mutant NSCLC Treated with Osimertinib: Implications for Consolidative Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;107:62-71.
    PubMed     Abstract available


    April 2020
  132. HRYCUSHKO B, van der Kogel AJ, Phillips L, Folkert M, et al
    Existence of a Dose-Length Effect in Spinal Nerves Receiving Single-Session Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:1010-1016.
    PubMed     Abstract available


    March 2020
  133. ALBUQUERQUE K, Timmerman R
    In Reply to Dalwadi et al.
    Int J Radiat Oncol Biol Phys. 2020;106:889.
    PubMed    


  134. DALWADI SM, Bonnen MD, Ludwig MS
    In Regard to Albuquerque et al.
    Int J Radiat Oncol Biol Phys. 2020;106:888-889.
    PubMed    


  135. KLEMENT RJ, Sonke JJ, Allgauer M, Andratschke N, et al
    Correlating dose variables with local tumor control in stereotactic body radiotherapy for early stage non-small cell lung cancer: A modelling study on 1500 individual treatments.
    Int J Radiat Oncol Biol Phys. 2020 Mar 15. pii: S0360-3016(20)30897.
    PubMed     Abstract available


  136. KIRKPATRICK JP
    Classifying Leptomeningeal Disease: An Essential Element in Managing Advanced Metastatic Disease in the Central Nervous System.
    Int J Radiat Oncol Biol Phys. 2020;106:587-588.
    PubMed    


  137. VAN MARLEN P, Dahele M, Folkerts M, Abel E, et al
    Bringing FLASH to the Clinic: Treatment Planning Considerations for Ultrahigh Dose-Rate Proton Beams.
    Int J Radiat Oncol Biol Phys. 2020;106:621-629.
    PubMed     Abstract available


  138. SAMPATH S, Frankel P, Vecchio BD, Ruel N, et al
    Stereotactic Body Radiation Therapy to the Prostate Bed: Results of a Phase 1 Dose-Escalation Trial.
    Int J Radiat Oncol Biol Phys. 2020;106:537-545.
    PubMed     Abstract available


  139. REYNOLDS TA, Jensen AR, Bellairs EE, Ozer M, et al
    Dose Gradient Index for Stereotactic Radiosurgery/Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:604-611.
    PubMed     Abstract available


  140. KAMRAVA M, Chino JP, Beriwal S
    SAbR as an Alternative Boost Modality for Cervical Cancer: A Cautionary Exercise.
    Int J Radiat Oncol Biol Phys. 2020;106:472-474.
    PubMed    


  141. GIULIANI ME, Robinson CG, Salama JK, Daly ME, et al
    Oligoreview of Non-Small Cell Lung Cancer Oligometastases.
    Int J Radiat Oncol Biol Phys. 2020;106:455-459.
    PubMed    


    February 2020
  142. GIGLIOLI FR, Garibaldi C, Blanck O, Villaggi E, et al
    Dosimetric Multicenter Planning Comparison Studies for Stereotactic Body Radiation Therapy: Methodology and Future Perspectives.
    Int J Radiat Oncol Biol Phys. 2020;106:403-412.
    PubMed     Abstract available


  143. TENDLER II, Hartford A, Jermyn M, LaRochelle E, et al
    Experimentally Observed Cherenkov Light Generation in the Eye During Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2020;106:422-429.
    PubMed     Abstract available


  144. MACDONALD RL, Lee Y, Schasfoort J, Soliman H, et al
    Real-Time Infrared Motion Tracking Analysis for Patients Treated With Gated Frameless Image Guided Stereotactic Radiosurgery.
    Int J Radiat Oncol Biol Phys. 2020;106:413-421.
    PubMed     Abstract available


  145. TRIFILETTI DM, Ballman KV, Brown PD, Anderson SK, et al
    Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3).
    Int J Radiat Oncol Biol Phys. 2020;106:255-260.
    PubMed     Abstract available


  146. FULLER D, Wurzer J, Shirazi R, Bridge S, et al
    Retreatment for Local Recurrence of Prostatic Carcinoma After Prior Therapeutic Irradiation: Efficacy and Toxicity of HDR-Like SBRT.
    Int J Radiat Oncol Biol Phys. 2020;106:291-299.
    PubMed     Abstract available


  147. REDMOND KJ, Sciubba D, Khan M, Gui C, et al
    A Phase 2 Study of Post-Operative Stereotactic Body Radiation Therapy (SBRT) for Solid Tumor Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2020;106:261-268.
    PubMed     Abstract available


    January 2020
  148. DAUTRUCHE A, Filion E, Mathieu D, Bahig H, et al
    To biopsy or not to biopsy: A matched cohort analysis of early stage lung cancer treated with stereotactic radiation with or without histologic confirmation.
    Int J Radiat Oncol Biol Phys. 2020 Jan 28. pii: S0360-3016(20)30124.
    PubMed     Abstract available


  149. MANYAM BV, Verdecchia K, Videtic GMM, Zhuang T, et al
    Validation of RTOG 0813 Proximal Bronchial Tree Constraints for Pulmonary Toxicity with Stereotactic Body Radiation Therapy for Central Non-Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2020 Jan 24. pii: S0360-3016(20)30068.
    PubMed     Abstract available


  150. FARUQI S, Ruschin M, Soliman H, Myrehaug S, et al
    Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2020 Jan 9. pii: S0360-3016(19)34476.
    PubMed     Abstract available


  151. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    In Reply to Mendenhall et al.
    Int J Radiat Oncol Biol Phys. 2020;106:221.
    PubMed    


  152. MENDENHALL WM, Holtzman AL, Dagan R, Bryant CM, et al
    In Regard to Sher et al.
    Int J Radiat Oncol Biol Phys. 2020;106:220-221.
    PubMed    


  153. MESKO S, Wang H, Tung S, Wang C, et al
    Estimating PTV Margins in Head and Neck Stereotactic Ablative Radiation Therapy (SABR) Through Target Site Analysis of Positioning and Intrafractional Accuracy.
    Int J Radiat Oncol Biol Phys. 2020;106:185-193.
    PubMed     Abstract available


  154. DUIJM M, van der Voort van Zyp NC, van de Vaart P, Oomen-de Hoop E, et al
    Predicting High-Grade Esophagus Toxicity After Treating Central Lung Tumors With Stereotactic Radiation Therapy Using a Normal Tissue Complication Probability Model.
    Int J Radiat Oncol Biol Phys. 2020;106:73-81.
    PubMed     Abstract available


  155. LI R, Shinde A, Novak J, Vapiwala N, et al
    Temporal Trends of Resident Experience in External Beam Radiation Therapy Cases: Analysis of ACGME Case Logs from 2007 to 2018.
    Int J Radiat Oncol Biol Phys. 2020;106:37-42.
    PubMed     Abstract available


    December 2019
  156. RADES D, Cacicedo J, Conde-Moreno AJ, Segedin B, et al
    Precision radiotherapy for metastatic spinal cord compression: Final results of the PRE-MODE Trial.
    Int J Radiat Oncol Biol Phys. 2019 Dec 5. pii: S0360-3016(19)34460.
    PubMed     Abstract available


  157. KIRKPATRICK JP, Fecci PE
    Offer Hypofractionated SRS... If Her Performance Status Is Good.
    Int J Radiat Oncol Biol Phys. 2019;105:940-941.
    PubMed    


  158. LI R, Vora N
    Radiation Therapy for Surgically Resected Brain Metastasis: What Is Your Approach?
    Int J Radiat Oncol Biol Phys. 2019;105:938-939.
    PubMed    


  159. HARDY-ABELOOS C, Lazarev S, Ru M, Kim E, et al
    Safety and Efficacy of Liver Stereotactic Body Radiation Therapy for Hepatocellular Carcinoma After Segmental Transarterial Radioembolization.
    Int J Radiat Oncol Biol Phys. 2019;105:968-976.
    PubMed     Abstract available


  160. OLSON R, Senan S, Harrow S, Gaede S, et al
    Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial.
    Int J Radiat Oncol Biol Phys. 2019;105:943-947.
    PubMed     Abstract available


    November 2019
  161. SHI S, Sandhu N, Jin MC, Wang E, et al
    Stereotactic radiosurgery for resected brain metastases: single-institutional experience of over 500 cavities.
    Int J Radiat Oncol Biol Phys. 2019 Nov 27. pii: S0360-3016(19)34058.
    PubMed     Abstract available


  162. ALBUQUERQUE K, Tumati V, Lea J, Ahn C, et al
    A Phase II Trial of Stereotactic Ablative Radiotherapy as a Boost for Locally Advanced Cervical Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Nov 4. pii: S0360-3016(19)33966.
    PubMed     Abstract available


  163. MITIN T, Henry A, Choudhury A, Chen RC, et al
    SBRT for Localized Prostate Cancer: Is it Ready for Take-Off?
    Int J Radiat Oncol Biol Phys. 2019;105:618-620.
    PubMed    


  164. SPENCER K, Velikova G, Henry A, Westhoff P, et al
    Net Pain Relief After Palliative Radiation Therapy for Painful Bone Metastases: A Useful Measure to Reflect Response Duration? A Further Analysis of the Dutch Bone Metastasis Study.
    Int J Radiat Oncol Biol Phys. 2019;105:559-566.
    PubMed     Abstract available


  165. JIANG NY, Dang AT, Yuan Y, Chu FI, et al
    Multi-Institutional Analysis of Prostate-Specific Antigen Kinetics After Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;105:628-636.
    PubMed     Abstract available


    October 2019
  166. SHEPARD MJ, Sheehan JP
    The Choice of Postoperative Stereotactic Radiosurgery After Resection of an Isolated Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2019 Oct 24. pii: S0360-3016(18)30959.
    PubMed    


  167. TURNER BE, Prabhu RS, Burri SH, Brown PD, et al
    Nodular Leptomeningeal Disease - A Distinct Pattern of Recurrence After Post-Resection Stereotactic Radiosurgery for Brain Metastases: A Multi-Institutional Study of Inter-Observer Reliability.
    Int J Radiat Oncol Biol Phys. 2019 Oct 9. pii: S0360-3016(19)33867.
    PubMed     Abstract available


  168. PASQUIER D, Peiffert D, Nickers P, Maingon P, et al
    A multicentre phase II study of hypofractionated stereostatic boost in intermediate risk prostate carcinoma: a 5-year analysis of the CKNO-PRO trial.
    Int J Radiat Oncol Biol Phys. 2019 Oct 8. pii: S0360-3016(19)33863.
    PubMed     Abstract available


  169. KANG J, Ning MS, Feng H, Li H, et al
    Predicting 5-Year Progression and Survival Outcomes for Early-Stage Non-Small Cell Lung Cancer Treated with Stereotactic Ablative Radiotherapy: Development and Validation of Robust Prognostic Nomograms.
    Int J Radiat Oncol Biol Phys. 2019 Oct 3. pii: S0360-3016(19)33861.
    PubMed     Abstract available


  170. MCCLELLAND S 3RD, Saito NG
    An Intracranial Hemorrhage Wrapped in an Enigma.
    Int J Radiat Oncol Biol Phys. 2019;105:242-243.
    PubMed    


  171. ZHANG Y, Schoenhals J, Christie A, Mohamad O, et al
    Stereotactic Ablative Radiation Therapy (SAbR) Used to Defer Systemic Therapy in Oligometastatic Renal Cell Cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:367-375.
    PubMed     Abstract available


  172. SHEN PC, Chang WC, Lo CH, Yang JF, et al
    Comparison of Stereotactic Body Radiation Therapy and Transarterial Chemoembolization for Unresectable Medium-Sized Hepatocellular Carcinoma.
    Int J Radiat Oncol Biol Phys. 2019;105:307-318.
    PubMed     Abstract available


    September 2019
  173. OZSAHIN M, Slotman BJ, Bourhis J
    Reproductive Viability of Cells Following Preoperative Stereotactic Ablative Radiotherapy.
    Int J Radiat Oncol Biol Phys. 2019;105:233-234.
    PubMed    


  174. YOUNG MR, Decker RH
    SBRT for Early Stage Laryngeal Cancer: Progress, But Not Quite Ready for Prime Time.
    Int J Radiat Oncol Biol Phys. 2019;105:121-123.
    PubMed    


  175. MUELLER AC, Karam SD
    SBRT for Early Stage Larynx: A Go or No Go? It's All in the Delivery.
    Int J Radiat Oncol Biol Phys. 2019;105:119-120.
    PubMed    


  176. KANG BH, Yu T, Kim JH, Park JM, et al
    Early Closure of a Phase 1 Clinical Trial for SABR in Early-Stage Glottic Cancer.
    Int J Radiat Oncol Biol Phys. 2019;105:104-109.
    PubMed     Abstract available


    August 2019
  177. QIAN JM, Yu JB, Mahajan A, Goldberg SB, et al
    Frequent use of local therapy underscores need for multidisciplinary care in the management of patients with melanoma brain metastases treated with PD-1 inhibitors.
    Int J Radiat Oncol Biol Phys. 2019 Aug 31. pii: S0360-3016(19)33742.
    PubMed     Abstract available


  178. NAVARRIA P, Pessina F, Clerici E, Franceschini D, et al
    Surgery followed by hypofractionated radiosurgery on the tumor bed in oligometastatic patients with large brain metastases. Results of a Phase II study.
    Int J Radiat Oncol Biol Phys. 2019 Aug 31. pii: S0360-3016(19)33743.
    PubMed     Abstract available


  179. SINGH AK, Gomez-Suescun JA, Stephans KL, Bogart JA, et al
    One versus three fractions of stereotactic body radiation therapy for peripheral stage I-II non-small cell lung cancer: a randomized, multi-institution, phase 2 trial.
    Int J Radiat Oncol Biol Phys. 2019 Aug 22. pii: S0360-3016(19)33653.
    PubMed     Abstract available


  180. LIU C, Sun B, Hu X, Zhang Y, et al
    Stereotactic ablative radiotherapy for pulmonary recurrence-based oligometastatic non-small cell lung cancer: survival and prognostic value of regulatory T cells.
    Int J Radiat Oncol Biol Phys. 2019 Aug 19. pii: S0360-3016(19)33646.
    PubMed     Abstract available


  181. BRUYNZEEL AME, Tetar SU, Oei SS, Senan S, et al
    A prospective single-arm phase II study of stereotactic magnetic-resonance-guided adaptive radiotherapy for prostate cancer: Early toxicity results.
    Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33640.
    PubMed     Abstract available


  182. DEEK MP, Yu C, Phillips R, Song DY, et al
    Radiotherapy In The Definitive Management Of Oligometastatic Prostate Cancer: The Johns Hopkins Experience.
    Int J Radiat Oncol Biol Phys. 2019 Aug 13. pii: S0360-3016(19)33641.
    PubMed     Abstract available


  183. KNUTSON NC, Samson PP, Hugo GD, Goddu SM, et al
    Radiation Therapy Workflow and Dosimetric Analysis from a Phase 1/2 Trial of Noninvasive Cardiac Radioablation for Ventricular Tachycardia.
    Int J Radiat Oncol Biol Phys. 2019;104:1114-1123.
    PubMed     Abstract available


  184. ONG WL, Foroudi F, Milne RL, Millar JL, et al
    Are We Choosing Wisely in Radiation Oncology Practice-Findings From an Australian Population-Based Study.
    Int J Radiat Oncol Biol Phys. 2019;104:1012-1016.
    PubMed     Abstract available


    July 2019
  185. PASQUIER D, Martinage G, Janoray G, Rojas DP, et al
    Salvage stereotactic body radiotherapy for local prostate cancer recurrence after radiotherapy: a retrospective multicentre study of the GETUG.
    Int J Radiat Oncol Biol Phys. 2019 Jul 22. pii: S0360-3016(19)33494.
    PubMed     Abstract available


  186. MOHIDEEN N, Kavanagh BD
    Model Insurance Coverage Policies: The Power of Suggestion, the Force of Evidence.
    Int J Radiat Oncol Biol Phys. 2019;104:745-747.
    PubMed    


  187. HRYCUSHKO B, van der Kogel AJ, Phillips L, Folkert MR, et al
    Spinal Nerve Tolerance to Single-Session Stereotactic Ablative Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;104:845-851.
    PubMed     Abstract available


  188. SUNDAHL N, Seremet T, Van Dorpe J, Neyns B, et al
    Phase 2 Trial of Nivolumab Combined With Stereotactic Body Radiation Therapy in Patients With Metastatic or Locally Advanced Inoperable Melanoma.
    Int J Radiat Oncol Biol Phys. 2019;104:828-835.
    PubMed     Abstract available


  189. FINAZZI T, Palacios MA, Spoelstra FOB, Haasbeek CJA, et al
    Role of On-Table Plan Adaptation in MR-Guided Ablative Radiation Therapy for Central Lung Tumors.
    Int J Radiat Oncol Biol Phys. 2019;104:933-941.
    PubMed     Abstract available


  190. ROACH MC, Thomas TO, Paravati AJ, Mahajan A, et al
    Differences in United States Insurance Payer Policies and American Society for Radiation Oncology's (ASTRO) Model Policy on Stereotactic Body Radiation Therapy (SBRT).
    Int J Radiat Oncol Biol Phys. 2019;104:740-744.
    PubMed     Abstract available


  191. NGUYEN TK, Sahgal A, Detsky J, Soliman H, et al
    Single-Fraction Stereotactic Radiosurgery vs. Hippocampal-Avoidance Whole Brain Radiotherapy for Patients with 10-30 Brain Metastases: A Dosimetric Analysis.
    Int J Radiat Oncol Biol Phys. 2019 Jul 5. pii: S0360-3016(19)33443.
    PubMed     Abstract available


  192. JACKSON WC, Cuneo KC, Lawrence TS, Owen D, et al
    In Reply to Slovak et al.
    Int J Radiat Oncol Biol Phys. 2019;104:696-697.
    PubMed    


  193. WANG TJC
    Hypofractionated Radiation Therapy or Staged Stereotactic Radiosurgery for Large Brain Metastasis.
    Int J Radiat Oncol Biol Phys. 2019;104:484-485.
    PubMed    


  194. MENZEL P, Theodosopoulos P
    A Caudate Conundrum.
    Int J Radiat Oncol Biol Phys. 2019;104:481-482.
    PubMed    


  195. SAMPATH S, Rahmanuddin S, Sahoo P, Frankel P, et al
    Change in apparent diffusion coefficient is associated with local failure after stereotactic body radiation therapy for non-small cell lung cancer: a prospective clinical trial.
    Int J Radiat Oncol Biol Phys. 2019 Jul 1. pii: S0360-3016(19)33424.
    PubMed     Abstract available


    June 2019
  196. VIDETIC GM
    In Reply to Yilmaz et al.
    Int J Radiat Oncol Biol Phys. 2019;104:467.
    PubMed    


  197. YILMAZ MT, Hurmuz P, Cengiz M
    In Regard to Videtic et al.
    Int J Radiat Oncol Biol Phys. 2019;104:466-467.
    PubMed    


  198. LAVIGNE J, Suissa A, Verger N, Dos Santos M, et al
    Lung Stereotactic Arc Therapy in Mice: Development of Radiation Pneumopathy and Influence of HIF-1alpha Endothelial Deletion.
    Int J Radiat Oncol Biol Phys. 2019;104:279-290.
    PubMed     Abstract available


    May 2019
  199. YUAN Y, Aghdam N, King C, Fuller D, et al
    Testosterone Levels and Sexual Quality of Life Following Stereotactic Body Radiotherapy for Prostate Cancer: A Multi-Institutional Analysis of Prospective Trials.
    Int J Radiat Oncol Biol Phys. 2019 May 17. pii: S0360-3016(19)30727.
    PubMed     Abstract available


  200. WARDAK Z, Bland R, Ahn C, Xie XJ, et al
    A Phase 2 Clinical Trial of SABR Followed by Immediate Vertebroplasty for Spine Metastases.
    Int J Radiat Oncol Biol Phys. 2019;104:83-89.
    PubMed     Abstract available


  201. ZHU X, Ju X, Cao Y, Shen Y, et al
    Patterns of Local Failure After Stereotactic Body Radiation Therapy and Sequential Chemotherapy as Initial Treatment for Pancreatic Cancer: Implications of Target Volume Design.
    Int J Radiat Oncol Biol Phys. 2019;104:101-110.
    PubMed     Abstract available


  202. FRANCESCHINI D, De Rose F, Franzese C, Comito T, et al
    Predictive Factors for Response and Survival in a Cohort of Oligometastatic Patients Treated With Stereotactic Body Radiation Therapy.
    Int J Radiat Oncol Biol Phys. 2019;104:111-121.
    PubMed     Abstract available


  203. BALLAS LK, Luo C, Chung E, Kishan AU, et al
    Phase 1 Trial of SBRT to the Prostate Fossa After Prostatectomy.
    Int J Radiat Oncol Biol Phys. 2019;104:50-60.
    PubMed     Abstract available


    April 2019
  204. ALAYED Y, Loblaw A, Chu W, Al-Hanaqta M, et al
    Stereotactic Body Radiotherapy Boost for Intermediate Risk Prostate Cancer: A Phase 1 Dose Escalation Study.
    Int J Radiat Oncol Biol Phys. 2019 Apr 16. pii: S0360-3016(19)30624.
    PubMed     Abstract available


  205. JACKSON WC, Silva J, Hartman HE, Dess RT, et al
    Stereotactic Body Radiotherapy for Localized Prostate Cancer: A Systematic Review and Meta-Analysis of Over 6,000 Patients Treated On Prospective Studies.
    Int J Radiat Oncol Biol Phys. 2019 Apr 5. pii: S0360-3016(19)30612.
    PubMed     Abstract available


  206. HUGHES RT, Masters AH, McTyre ER, Farris MK, et al
    Initial SRS for patients with 5-15 brain metastases: results of a multi-institutional experience.
    Int J Radiat Oncol Biol Phys. 2019 Apr 5. pii: S0360-3016(19)30613.
    PubMed     Abstract available


  207. SIVA S, Ball DL
    Single Fraction SBRT for Early Stage Lung Cancer-Less is More?
    Int J Radiat Oncol Biol Phys. 2019;103:1085-1087.
    PubMed    


  208. RUSTHOVEN CG
    Small Cell Lung Cancer: PCI Uncertainty and Emerging Radiosurgery Interest.
    Int J Radiat Oncol Biol Phys. 2019;103:1034-1035.
    PubMed    


  209. GASPAR LE
    A Gray Zone Regarding Gray Matter.
    Int J Radiat Oncol Biol Phys. 2019;103:1033-1034.
    PubMed    


  210. WEGNER RE, Hasan S
    Observe the Brain and Preserve the Mind.
    Int J Radiat Oncol Biol Phys. 2019;103:1033.
    PubMed    


  211. SHINDE A, Amini A
    Challenging Current Conventions: Up-Front Stereotactic Radiosurgery Alone for Limited Brain Metastases in Small Cell Lung Cancer.
    Int J Radiat Oncol Biol Phys. 2019;103:1031-1032.
    PubMed    


  212. ADAMSON J, Carroll J, Trager M, Yoon SW, et al
    Delivered Dose Distribution Visualized Directly With Onboard kV-CBCT: Proof of Principle.
    Int J Radiat Oncol Biol Phys. 2019;103:1271-1279.
    PubMed     Abstract available


    March 2019
  213. SHER DJ, Timmerman RD, Nedzi L, Ding C, et al
    Phase I fractional dose escalation study of equipotent stereotactic radiotherapy regimens for early-stage glottic larynx cancer.
    Int J Radiat Oncol Biol Phys. 2019 Mar 14. pii: S0360-3016(19)30323.
    PubMed     Abstract available


  214. MIYAWAKI E, Kenmotsu H, Mori K, Harada H, et al
    Optimal Sequence of Local and EGFR-TKI Therapy for EGFR-mutant NSCLC with Brain Metastases Stratified by Number of Brain Metastases.
    Int J Radiat Oncol Biol Phys. 2019 Mar 6. pii: S0360-3016(19)30307.
    PubMed     Abstract available


    February 2019
  215. D'AGOSTINO GR, di Brina L, Mancosu P, Franzese C, et al
    Re-Irradiation of Locally Recurrent Prostate Cancer with Volumetric Modulated Arc Therapy (Vmat).
    Int J Radiat Oncol Biol Phys. 2019 Feb 27. pii: S0360-3016(19)30285.
    PubMed     Abstract available


  216. POTTERS L, Rana Z, Lee L, Cox BW, et al
    Outcomes of a Dose-Escalated Stereotactic Body Radiation Phase I/II trial for Patients with Low and Intermediate-Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Feb 2. pii: S0360-3016(19)30183.
    PubMed     Abstract available


    January 2019
  217. ZELEFSKY MJ, Kollmeier M, McBride S, Varghese M, et al
    5-Year Outcomes of a Phase I Dose Escalation Study Using Stereotactic Body Radiosurgery for Patients with Low and Intermediate Risk Prostate Cancer.
    Int J Radiat Oncol Biol Phys. 2019 Jan 3. pii: S0360-3016(18)34227.
    PubMed     Abstract available


    December 2018
  218. VIDETIC GM, Paulus R, Singh AK, Chang JY, et al
    Long term follow-up on NRG Oncology RTOG 0915 (NCCTG N0927): A randomized phase II study comparing 2 stereotactic body radiation therapy schedules for medically inoperable patients with stage I peripheral non-small cell lung cancer.
    Int J Radiat Oncol Biol Phys. 2018 Dec 1. pii: S0360-3016(18)34048.
    PubMed     Abstract available


    November 2018
  219. ALAYED Y, Cheung P, Vesprini D, Liu S, et al
    SABR in high risk prostate cancer: outcomes from two prospective clinical trials with and without elective nodal irradiation.
    Int J Radiat Oncol Biol Phys. 2018 Nov 13. pii: S0360-3016(18)33997.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Neurosurgery is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: